98 related articles for article (PubMed ID: 25683868)
1. Percutaneous absorption of methimazole: an in vitro study of the absorption pharmacokinetics for two different vehicles.
Hill KE; Mills PC; Jones BR; Bolwell CF; Aberdein D; Chambers JP
J Vet Pharmacol Ther; 2015 Dec; 38(6):581-9. PubMed ID: 25683868
[TBL] [Abstract][Full Text] [Related]
2. Regional variations in percutaneous absorption of methimazole: an in vitro study on cat skin.
Hill KE; Chambers JP; Jones BR; Bolwell CF; Aberdein D; Mills PC
J Vet Pharmacol Ther; 2015 Dec; 38(6):616-8. PubMed ID: 25728360
[TBL] [Abstract][Full Text] [Related]
3. Trans-pinnal movement of methimazole: an in vitro study showing that methimazole can cross from the inner to outer pinna of cats.
Hill KE; Chambers JP; Jones BR; Bolwell CF; Aberdein D; Mills PC
J Feline Med Surg; 2015 Dec; 17(12):1005-11. PubMed ID: 25600079
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats.
Hoffman SB; Yoder AR; Trepanier LA
J Vet Pharmacol Ther; 2002 Jun; 25(3):189-93. PubMed ID: 12081614
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of methimazole in a novel lipophilic formulation administered transdermally to healthy cats.
Hill KE; Gieseg MA; Bridges J; Chambers JP
N Z Vet J; 2014 Jul; 62(4):208-13. PubMed ID: 24350893
[TBL] [Abstract][Full Text] [Related]
6. [Preparation and "in vitro" and "in vivo" evaluation of a transdermal formulation containing methimazole].
Monti D; Chetoni P; Bonaldi S; Mariotti Bianchi L; Saettone MF
Boll Chim Farm; 1996 Feb; 135(2):139-41. PubMed ID: 9044563
[No Abstract] [Full Text] [Related]
7. Transdermal methimazole treatment in cats with hyperthyroidism.
Hoffmann G; Marks SL; Taboada J; Hosgood GL; Wolfsheimer KJ
J Feline Med Surg; 2003 Apr; 5(2):77-82. PubMed ID: 12670432
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of a novel lipophilic formulation of methimazole for the once daily transdermal treatment of cats with hyperthyroidism.
Hill KE; Gieseg MA; Kingsbury D; Lopez-Villalobos N; Bridges J; Chambers P
J Vet Intern Med; 2011; 25(6):1357-65. PubMed ID: 22092628
[TBL] [Abstract][Full Text] [Related]
9. Ex-vivo study of the percutaneous absorption of a tramadol formulation through feline inner pinna skin.
Beuve MS; Espana B; Pin D; Prouillac C
Res Vet Sci; 2022 Dec; 151():57-63. PubMed ID: 35868201
[TBL] [Abstract][Full Text] [Related]
10. Duration of t4 suppression in hyperthyroid cats treated once and twice daily with transdermal methimazole.
Boretti FS; Sieber-Ruckstuhl NS; Schäfer S; Baumgartner C; Riond B; Hofmann-Lehmann R; Reusch CE
J Vet Intern Med; 2013; 27(2):377-81. PubMed ID: 23398124
[TBL] [Abstract][Full Text] [Related]
11. Transdermal application of methimazole in hyperthyroid cats: a long-term follow-up study.
Boretti FS; Sieber-Ruckstuhl NS; Schäfer S; Gerber B; Baumgartner C; Riond B; Hofmann-Lehmann R; Reusch CE
J Feline Med Surg; 2014 Jun; 16(6):453-9. PubMed ID: 24174499
[TBL] [Abstract][Full Text] [Related]
12. Safety of topical methimazole for the treatment of melasma. Transdermal absorption, the effect on thyroid function and cutaneous adverse effects.
Kasraee B; Safaee Ardekani GH; Parhizgar A; Handjani F; Omrani GR; Samani M; Nikbakhsh M; Tanideh N; Eshraghian A; Sorg O; Saurat JH
Skin Pharmacol Physiol; 2008; 21(6):300-5. PubMed ID: 18667842
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of controlled-release carbimazole tablets support once daily dosing in cats.
Frénais R; Burgaud S; Horspool LJ
J Vet Pharmacol Ther; 2008 Jun; 31(3):213-9. PubMed ID: 18471142
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism.
Sartor LL; Trepanier LA; Kroll MM; Rodan I; Challoner L
J Vet Intern Med; 2004; 18(5):651-5. PubMed ID: 15515580
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of methimazole in cats after a single oral dose of controlled-release carbimazole or sugar-coated methimazole (thiamazole).
Longhofer SL; Martín-Jiménez T; Soni-Gupta J
Vet Ther; 2010; 11(3):E1-7. PubMed ID: 20960416
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and in vitro release of new transdermal methimazole as alternative to oral delivery.
Morales ME; Clarés B; López-Viota M; Ruiz MA
Drug Deliv; 2009 Jan; 16(1):1-10. PubMed ID: 19555302
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Percutaneous Absorption of Ketoprofen Using the Franz Skin Finite Dose Model.
Bassani AS; Banov D; Phan H
Postgrad Med; 2016; 128(2):262-7. PubMed ID: 26788899
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and safety of transdermal methimazole in the treatment of feline hyperthyroidism.
Lécuyer M; Prini S; Dunn ME; Doucet MY
Can Vet J; 2006 Feb; 47(2):131-5. PubMed ID: 16579038
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of methimazole in normal cats and cats with hyperthyroidism.
Trepanier LA; Peterson ME; Aucoin DP
Res Vet Sci; 1991 Jan; 50(1):69-74. PubMed ID: 2047595
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the percutaneous absorption of promethazine hydrochloride, in vitro, using the human ex vivo skin model.
Bassani AS; Banov D; Lehman PA
Int J Pharm Compd; 2008; 12(3):270-3. PubMed ID: 23969717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
